Hikma Pharmaceuticals Share News (HIK)
HIK Share
HIK Share
HIK Share
HIK Share
HIK
HIK Share
HIK Level 2
HIK Live
HIK Broker
HIK Directors
HIK Financial
HIK
HIK Short
HIK
Last checked at -
Hikma Pharmaceuticals still thinks revenue growth for 2010 will be in the low teens and gross margin will be higher than in 2009. The Jordan-based firm is "performing well" this year, with strong growth for the branded business in the Middle East and North Africa (Mena) region during the second hal
Read moreAlfredo Villa, chief executive of Brainspark, has bought 2.1m shares £2.6m or 125p a share. Brainspark is an investment company with a primary portfolio in Italy encompassing interactive media, leisure, entertainment and financial services. As well as being the chief executivee of Brainspark, Vill
Read moreSmiths, the technology group, enjoyed steady gains on the stock market yesterday as investors woke up to what could be an unexpected boost to its bottom line. The interest was triggered by the recently foiled cargo bomb plot, in which explosive devices were posted in Yemen with the freight firms UPS
Read moreThe movements of the FTSE 100 index appeared to be directed by a lackadaisical Grand Old Duke of York today, and the blue-chip index finished (more or less) neither up nor down. British Airways was lower even though it swung to a profit in the first half as the airline improved yields and cut costs
Read moreLondon has finally pulled itself back into the blue helped by a solid start on Wall Street after GDP numbers disappointed slightly. Over here, GfK NOP's consumer confidence index improved to -19 in October, confounding economists' expectations of a slide to -22 or even lower. The survey was taken b
Read moreDespite an 'excellent improvement' in profits and an upgraded target price, Panmure Gordon is sticking with its 'hold' recommendation for British Airways (BA) due to economic uncertainty. Half-year turnover for the airline rose by 8.4% to £4.4bn. BA also swung to a pre-tax profit of £158m from last
Read moreThe purchase of a multi-source injectables business by Hikma Pharmaceuticals looks a good one 'at first glance' and has prompted KBC Peel Hunt to up its price target for Hikma, but not by enough to justify changing its neutral stance on the stock. The biotechnology and pharmaceuticals company anno
Read moreWeak miners and a poor reception to results from British Airways have discouraged buyers generally, despite some encouraging news on the consumer confidence front. GfK NOP's consumer confidence index improved to -19 in October, confounding economists' expectations of a slide to -22 or even lower. T
Read moreLondon has made modest early gains despite a poor session in Asia and unconvincing display on Wall Street overnight. British Airways is lower even though it swung to a profit in the first half as the airline improved yields and cut costs. It made a pre-tax profit of £158m in the six months ended 30
Read moreHikma Pharmaceuticals becomes the second largest injectables supplier in the US after agreeing to pay $112m (£70m) in cash for Baxter Healthcare's generic injectables business. The Jordan-based firm said the acquired portfolio includes 41 products in over 150 dosage strengths and forms across 23 th
Read moreAfter a sluggish start to the day, shares closed with good gains following a lively start on Wall Street. Better than expected profits on the back of a decline in provisions for bad loans at Citigroup sparked buying interest. Mining giants BHP Billiton and Rio Tinto have confirmed that their propo
Read moreLeading shares added to the morning's gains over the lunch time session though miners remain under a cloud as metal prices retreat. Mining giants BHP Billiton and Rio Tinto have confirmed that their proposed $116bn Pilbara iron ore joint venture is dead in the water. The companies had agreed in D
Read moreThe blue-chip index ended the morning barely changed which, given that virtually all of the mining stocks were lower, counts as some sort of moral victory. Mining giants BHP Billiton and Rio Tinto have confirmed that their proposed $116bn Pilbara iron ore joint venture is dead in the water. The c
Read moreLondon has made a cautious start to the day with miners weak though a burst of M&A has lifted the mood elsewhere. Mining giants BHP Billiton and Rio Tinto have confirmed that their proposed $116bn Pilbara iron ore joint venture is dead in the water. The companies had agreed in December of last ye
Read moreJordan-based pharmaceuticals firm Hikma has sorted out its dispute with Mutual Pharmaceutical relating to the sale of oral colchicine tablets. Hikma's subsidiary and US agent, West-Ward Pharmaceutical, has discontinued its sales of oral colchicine until approval of its New Drug Application by the U
Read more
Last checked at